New Drug Approvals Archive

Get news by email or subscribe to our news feeds.

July 2005

July 22

Rozerem (ramelteon) Tablets

Date of Approval: July 22, 2005
Company: Takeda Pharmaceuticals North America, Inc.
Treatment for: Insomnia

Rozerem (ramelteon) is an orally active hypnotic indicated for the treatment of insomnia characterized by difficulty with sleep onset.

Rozerem (ramelteon) FDA Approval History

Hide
(web4)